Cargando…
Complex of C(60) Fullerene with Doxorubicin as a Promising Agent in Antitumor Therapy
The main aim of this work was to evaluate the effect of doxorubicin in complex with C(60) fullerene (C(60) + Dox) on the growth and metastasis of Lewis lung carcinoma in mice and to perform a primary screening of the potential mechanisms of C(60) + Dox complex action. We found that volume of tumor f...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695471/ https://www.ncbi.nlm.nih.gov/pubmed/26714861 http://dx.doi.org/10.1186/s11671-015-1206-7 |
_version_ | 1782407643306917888 |
---|---|
author | Prylutska, Svitlana V. Skivka, Larysa M. Didenko, Gennadiy V. Prylutskyy, Yuriy I. Evstigneev, Maxim P. Potebnya, Grygoriy P. Panchuk, Rostyslav R. Stoika, Rostyslav S. Ritter, Uwe Scharff, Peter |
author_facet | Prylutska, Svitlana V. Skivka, Larysa M. Didenko, Gennadiy V. Prylutskyy, Yuriy I. Evstigneev, Maxim P. Potebnya, Grygoriy P. Panchuk, Rostyslav R. Stoika, Rostyslav S. Ritter, Uwe Scharff, Peter |
author_sort | Prylutska, Svitlana V. |
collection | PubMed |
description | The main aim of this work was to evaluate the effect of doxorubicin in complex with C(60) fullerene (C(60) + Dox) on the growth and metastasis of Lewis lung carcinoma in mice and to perform a primary screening of the potential mechanisms of C(60) + Dox complex action. We found that volume of tumor from mice treated with the C(60) + Dox complex was 1.4 times less than that in control untreated animals. The number of metastatic foci in lungs of animals treated with C(60) + Dox complex was two times less than that in control untreated animals. Western blot analysis of tumor lysates revealed a significant decrease in the level of heat-shock protein 70 in animals treated with C(60) + Dox complex. Moreover, the treatment of tumor-bearing mice was accompanied by the increase of cytotoxic activity of immune cells. Thus, the potential mechanisms of antitumor effect of C(60) + Dox complex include both its direct action on tumor cells by inducing cell death and increasing of stress sensitivity and an immunomodulating effect. The obtained results provide a scientific basis for further application of C(60) + Dox nanocomplexes as treatment agents in cancer chemotherapy. |
format | Online Article Text |
id | pubmed-4695471 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-46954712016-01-08 Complex of C(60) Fullerene with Doxorubicin as a Promising Agent in Antitumor Therapy Prylutska, Svitlana V. Skivka, Larysa M. Didenko, Gennadiy V. Prylutskyy, Yuriy I. Evstigneev, Maxim P. Potebnya, Grygoriy P. Panchuk, Rostyslav R. Stoika, Rostyslav S. Ritter, Uwe Scharff, Peter Nanoscale Res Lett Nano Express The main aim of this work was to evaluate the effect of doxorubicin in complex with C(60) fullerene (C(60) + Dox) on the growth and metastasis of Lewis lung carcinoma in mice and to perform a primary screening of the potential mechanisms of C(60) + Dox complex action. We found that volume of tumor from mice treated with the C(60) + Dox complex was 1.4 times less than that in control untreated animals. The number of metastatic foci in lungs of animals treated with C(60) + Dox complex was two times less than that in control untreated animals. Western blot analysis of tumor lysates revealed a significant decrease in the level of heat-shock protein 70 in animals treated with C(60) + Dox complex. Moreover, the treatment of tumor-bearing mice was accompanied by the increase of cytotoxic activity of immune cells. Thus, the potential mechanisms of antitumor effect of C(60) + Dox complex include both its direct action on tumor cells by inducing cell death and increasing of stress sensitivity and an immunomodulating effect. The obtained results provide a scientific basis for further application of C(60) + Dox nanocomplexes as treatment agents in cancer chemotherapy. Springer US 2015-12-29 /pmc/articles/PMC4695471/ /pubmed/26714861 http://dx.doi.org/10.1186/s11671-015-1206-7 Text en © Prylutska et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Nano Express Prylutska, Svitlana V. Skivka, Larysa M. Didenko, Gennadiy V. Prylutskyy, Yuriy I. Evstigneev, Maxim P. Potebnya, Grygoriy P. Panchuk, Rostyslav R. Stoika, Rostyslav S. Ritter, Uwe Scharff, Peter Complex of C(60) Fullerene with Doxorubicin as a Promising Agent in Antitumor Therapy |
title | Complex of C(60) Fullerene with Doxorubicin as a Promising Agent in Antitumor Therapy |
title_full | Complex of C(60) Fullerene with Doxorubicin as a Promising Agent in Antitumor Therapy |
title_fullStr | Complex of C(60) Fullerene with Doxorubicin as a Promising Agent in Antitumor Therapy |
title_full_unstemmed | Complex of C(60) Fullerene with Doxorubicin as a Promising Agent in Antitumor Therapy |
title_short | Complex of C(60) Fullerene with Doxorubicin as a Promising Agent in Antitumor Therapy |
title_sort | complex of c(60) fullerene with doxorubicin as a promising agent in antitumor therapy |
topic | Nano Express |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695471/ https://www.ncbi.nlm.nih.gov/pubmed/26714861 http://dx.doi.org/10.1186/s11671-015-1206-7 |
work_keys_str_mv | AT prylutskasvitlanav complexofc60fullerenewithdoxorubicinasapromisingagentinantitumortherapy AT skivkalarysam complexofc60fullerenewithdoxorubicinasapromisingagentinantitumortherapy AT didenkogennadiyv complexofc60fullerenewithdoxorubicinasapromisingagentinantitumortherapy AT prylutskyyyuriyi complexofc60fullerenewithdoxorubicinasapromisingagentinantitumortherapy AT evstigneevmaximp complexofc60fullerenewithdoxorubicinasapromisingagentinantitumortherapy AT potebnyagrygoriyp complexofc60fullerenewithdoxorubicinasapromisingagentinantitumortherapy AT panchukrostyslavr complexofc60fullerenewithdoxorubicinasapromisingagentinantitumortherapy AT stoikarostyslavs complexofc60fullerenewithdoxorubicinasapromisingagentinantitumortherapy AT ritteruwe complexofc60fullerenewithdoxorubicinasapromisingagentinantitumortherapy AT scharffpeter complexofc60fullerenewithdoxorubicinasapromisingagentinantitumortherapy |